Frequently Asked Questions:
Due to the shutdown, COVID-19 significantly impacted the expansion of the cardiac resynchronization therapy market for cardiac consultations and treatments.
North America accounted for the most heightened share in the global market.
The market for CRT devices is driven by an increase in the prevalence of cardiac illnesses, a rise in the desire for invasive treatments, and lifestyle changes.
The Cardiac Resynchronization Therapy Defibrillators segment had a major share in the global market in 2022.
The hospitals & cardiac centers segment had a major share in the global market.